2026 International Spring Forum
April 15, 2026 | 12:00 PM EST
Upcoming Webinar
Additional NDC, due to Packaging Change of tivozanib (Fotivda®)
Date: October 3, 2025 | 2:00 PM
When: Friday, October 3 | 2 p.m. EST
Medication changes can cause delays if teams aren’t ready. Starting October 6, 2025, the 1.34 mg and 0.89 mg strengths of tivozanib will have new NDCs because of a packaging update.
In this session, Mike McDole, MBA (AVEO Oncology) will explain what’s changing, how to update ordering and billing systems, and what to check now to avoid delays and confusion for your patients.
For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.
Login to Watch this Webinar
To watch the live webinar, login to your account or register to gain access to our exclusive content.
Additional Upcoming Webinars

Upcoming Webinar
Optimizing DLBCL Patient Outcomes with clonoSEQ MRD Monitoring
September 29, 2025 | 2:00 PM

September 30, 2025 | 5:00 PM

Upcoming Webinar
Additional NDC, due to Packaging Change of tivozanib (Fotivda®)
October 3, 2025 | 2:00 PM